Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tonix Pharmaceuticals Holding Corp. - Common Stock
(NQ:
TNXP
)
27.75
-0.86 (-3.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tonix Pharmaceuticals Holding Corp. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
June 12, 2024
Via
Benzinga
FedEx Layoffs 2024: What to Know About the Latest FDX Job Cuts
June 12, 2024
FedEx layoffs will have the delivery company cutting up to 2,000 jobs in Europe as demand for its services are waning after the pandemic.
Via
InvestorPlace
Topics
Workforce
Dow Surges Over 300 Points; US Inflation Rate Slows In May
June 12, 2024
Via
Benzinga
Topics
Economy
Stocks
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?
June 12, 2024
Tonix Pharmaceuticals stock is down on Wednesday after the company announced a proposed public offering for TNXP shares.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 12, 2024
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!
Via
InvestorPlace
New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain
February 26, 2024
Via
ACCESSWIRE
Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction
February 15, 2024
Via
ACCESSWIRE
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
June 12, 2024
Via
Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 10, 2024
Via
Benzinga
What's Going On With Tonix Pharmaceuticals (TNXP) Stock?
June 10, 2024
Tonix Pharmaceuticals shares are trading lower by 29% during Monday's session. The company effected a 1-for-32 reverse stock split of its common stock.
Via
Benzinga
SOUN Stock Alert: SoundHound AI Pays Off Debt Early
June 10, 2024
SoundHound AI stock is up on Monday as SOUN investors celebrate the company paying off all of its outstanding debts with cash to spare.
Via
InvestorPlace
Topics
Artificial Intelligence
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today?
June 10, 2024
Tonix Pharmaceuticals stock is down on Monday after shares of TNXP underwent a one-for-32 reverse stock split to avoid delisting.
Via
InvestorPlace
US Stocks Mixed; Perion Network Shares Plunge
June 10, 2024
Via
Benzinga
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 20, 2024
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Biotech Stocks to Dump Before They Go to Zero
April 09, 2024
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling.
Via
InvestorPlace
TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
April 01, 2024
TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?
April 01, 2024
Tonix Pharmaceuticals shares are trading lower by 7.2% Monday. The company last week announced the pricing of a $4.4 million registered direct offering.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 29, 2024
Via
Benzinga
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
March 28, 2024
Tonix Pharmaceuticals shares are trading lower by 22.3% Thursday afternoon. The company announced the pricing of a $4.4 million registered direct offering.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 28, 2024
Via
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 28, 2024
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...
Via
Benzinga
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
March 24, 2024
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million.
Via
InvestorPlace
New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV
February 29, 2024
Via
AB Newswire
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
February 25, 2024
When you want to light your afterburners, these ideas will do the trick.
Via
InvestorPlace
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics
February 13, 2024
Via
Get News
Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Getting Patients Addicted In Phase 3 Trial
February 09, 2024
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and Tonix Pharmaceuticals Holding Corp, a financial partner of Benzinga. The...
Via
Benzinga
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024
From
FN Media Group LLC
Via
GlobeNewswire
New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
February 01, 2024
Via
ACCESSWIRE
New Hope For Fibromyalgia Patients? Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
January 30, 2024
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and Tonix Pharmaceuticals Holding Corp, a financial partner of Benzinga. The...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.